Explore / Clinical trial
Clinical trial

Research Study for Major Depressive Disorder: Investigation of Glutamate Medications

Baylor College of MedicineCompletedPhase 4Started Dec 1, 200626 enrolledUnited StatesNCT00419003

Abstract

This study is examining the safety and effectiveness of two medications, ketamine and riluzole, in treating patients with treatment resistant major depressive disorder. This study will also examine the effectiveness of an FDA approved drug called lamotrigine in decreasing the potential side effects associated with ketamine.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

Major Depression

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.